Advanced Drainage Systems (WMS) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
23 Aug, 2026Executive summary
Net sales rose 21% year-over-year to $1,001 million, driven by strong growth in both Stormwater and Wastewater segments and the NDS acquisition, which contributed $94.7–$95 million.
Adjusted EBITDA increased 28.8% to $358.3 million, with margin expanding 230 basis points to 35.8%, among the highest in company history.
Net income from continuing operations rose 22.5% to $176.6 million; diluted EPS increased 22.8% to $2.26.
Growth was supported by diversified portfolio, disciplined price-cost management, material conversion, and operational execution.
Gross profit improved 23.5% to $408 million, reflecting favorable price/cost, manufacturing efficiencies, and NDS integration.
Financial highlights
Stormwater sales increased 24% to $809–$809.4 million, including $94.7–$95 million from NDS; organic stormwater sales up 9.7–10%.
Wastewater sales rose 7.5–8% to $191.7 million, led by tanks and advanced treatment.
Free cash flow totaled $203–$203.2 million for the quarter, down from $222.4 million year-over-year.
Adjusted EBITDA margin improved to 35.8% from 33.5% year-over-year.
Net sales reached $1,001 million in Q1 FY27, up from $830 million in Q1 FY26.
Outlook and guidance
Full-year/fiscal 2027 guidance: net sales of $3.35–$3.55 billion and adjusted EBITDA of $1.0–$1.05 billion.
Adjusted EBITDA margin projected at 29.6–29.9%, down 170–200 basis points from FY26.
Capital expenditures expected at approximately $200 million for the year.
Management expects sufficient liquidity to meet obligations for at least the next twelve months.
$25–$30 million in revenue was pulled forward into Q1 due to customer pre-buying ahead of price increases.
Latest events from Advanced Drainage Systems
- All proposals passed, including director elections and auditor ratification, with strong shareholder participation.WMS
AGM 2026 - Targeting >8% organic CAGR and >$1.2B EBITDA by FY30 through innovation and disciplined capital deployment.WMS
Investor Day 2026 - Strong financial results, performance-based executive pay, and enhanced ESG initiatives highlighted.WMS
Proxy filing - Votes will be held on directors, auditor ratification, and executive compensation.WMS
Proxy filing - Strong FY26 growth from acquisitions and product mix; FY27 outlook sees sales up but margins tighter.WMS
Q4 2026 - Flat Q2 sales, resilient margins, profit down; FY25 outlook reflects Orenco acquisition, cost pressures.WMS
Q2 2025 - Q1 sales up 4.8% to $815M; margin strong at 33.8%, but net income down 6.7%.WMS
Q1 2025 - FY25 net sales up 1% to $2.90B, with margin pressure and cautious FY26 outlook.WMS
Q4 2025 - Net sales up 4.3% in Q3 FY25, but net income and margins declined amid higher costs.WMS
Q3 2025